ZA895367B - Therapeutic use of the isopropyl ester derivative of monosialoganglioside in nervous pathologies with an inflammatory component - Google Patents

Therapeutic use of the isopropyl ester derivative of monosialoganglioside in nervous pathologies with an inflammatory component

Info

Publication number
ZA895367B
ZA895367B ZA895367A ZA895367A ZA895367B ZA 895367 B ZA895367 B ZA 895367B ZA 895367 A ZA895367 A ZA 895367A ZA 895367 A ZA895367 A ZA 895367A ZA 895367 B ZA895367 B ZA 895367B
Authority
ZA
South Africa
Prior art keywords
isopropyl ester
ester derivative
monosialoganglioside
therapeutic use
inflammatory component
Prior art date
Application number
ZA895367A
Other languages
English (en)
Inventor
Francesco Della Valle
Della Valle Francesco
Aurelio Romeo
Romeo Aurelio
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Spa filed Critical Fidia Spa
Publication of ZA895367B publication Critical patent/ZA895367B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
ZA895367A 1988-07-19 1989-07-14 Therapeutic use of the isopropyl ester derivative of monosialoganglioside in nervous pathologies with an inflammatory component ZA895367B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8848208A IT1224513B (it) 1988-07-19 1988-07-19 Uso terapeutico del derivato estere isopropilico del monosialogangliosi de in patologie ad interessamento nervoso con componente infiammatoria

Publications (1)

Publication Number Publication Date
ZA895367B true ZA895367B (en) 1990-04-25

Family

ID=11265246

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA895367A ZA895367B (en) 1988-07-19 1989-07-14 Therapeutic use of the isopropyl ester derivative of monosialoganglioside in nervous pathologies with an inflammatory component

Country Status (10)

Country Link
EP (1) EP0351784B1 (xx)
JP (1) JPH0278622A (xx)
AT (1) ATE97812T1 (xx)
AU (1) AU624164B2 (xx)
DE (1) DE68911049T2 (xx)
DK (1) DK354589A (xx)
ES (1) ES2061821T3 (xx)
IT (1) IT1224513B (xx)
PH (1) PH26117A (xx)
ZA (1) ZA895367B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09278653A (ja) * 1996-04-05 1997-10-28 Santen Pharmaceut Co Ltd 網膜疾患治療剤
US6998392B2 (en) * 2003-04-02 2006-02-14 Mti Meta Tech Inc. Formulation to treat or prevent parasitic infection
US8536140B2 (en) 2004-03-12 2013-09-17 Mti Meta Tech Inc. Methods for treating inflammatory bowel disease
US7851451B2 (en) 2004-03-12 2010-12-14 Mti Meta Tech Inc. Formulations for mediating inflammatory bowel disorders
CN104490837A (zh) * 2014-12-30 2015-04-08 哈尔滨医科大学科技开发总公司 单唾液酸四己糖神经节苷脂钠的口服制剂

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1199116B (it) * 1984-07-03 1988-12-30 Fidia Farmaceutici Derivati di gangliosidi

Also Published As

Publication number Publication date
DK354589D0 (da) 1989-07-18
AU3819089A (en) 1990-01-25
DE68911049T2 (de) 1994-06-01
ES2061821T3 (es) 1994-12-16
PH26117A (en) 1992-02-24
DE68911049D1 (de) 1994-01-13
EP0351784A2 (en) 1990-01-24
IT8848208A0 (it) 1988-07-19
DK354589A (da) 1990-01-20
EP0351784A3 (en) 1990-12-27
IT1224513B (it) 1990-10-04
AU624164B2 (en) 1992-06-04
EP0351784B1 (en) 1993-12-01
JPH0278622A (ja) 1990-03-19
ATE97812T1 (de) 1993-12-15

Similar Documents

Publication Publication Date Title
AU4658489A (en) Use of acetyl d-carnitine in the therapeutic treatment of glaucoma
CA2046943A1 (en) Process for producing an agent with the active substance flupirtine to combat muscular tension
AU589371B2 (en) Purine derivatives and use as therapeutic agent
EP0142426A3 (en) Ophthalmic formulation containing norfloxacin and related antibiotics
NL930044I1 (nl) Imidazo [1,2-a] pyridinederivaten de bereiding hiervan en de therapeutische toepassing
IE790756L (en) Cerebral therapeutic agent
AU584090B2 (en) Therapeutic use of GM1 in severe cerebral ischemic strokes pathologies
EP0315113A3 (en) Inner esters of gangliosides with analgesic-antiinflammatory activity
AU3459689A (en) Treatment of skin disorders
EP0235589A3 (en) Use of quinolone and naphthyridine antibiotics for the manufacture of ophthalmic medicaments
EP0351784A3 (en) Therapeutic use of the isopropyl ester derivative of monosialoganglioside in nervous pathologies with an inflammatory component
IT1249034B (it) Impiego del monosialoganglioside gm1 e del suo derivato estere interno per impedire l'instaurarsi della tolleranza nell'uomo all'effetto analgesico della morfina e analoghi
EP0352826A3 (en) Use of 5-aminosalicylic acid in the treatment of dermatological disorders
IT9021768A0 (it) Derivato della melatonina ad attivita' terapeutica in dermatologia
IT1098997B (it) Procedimento per l'applicazione di occhi di supporto su parti di costruzione da supportare in modo oscillabile
IT1189308B (it) L'impiego in terapeutica d'un derivato dell'acetammide
GB8912373D0 (en) Medicament for various skin and ulcer disorders
EP0389570A4 (en) High integrity liposomes and method of preration and use
AU603375B2 (en) Therapeutic agent for the treatment of disorders associated with cerebral ischemia
IT1232963B (it) Composizioni farmaceutiche topiche contenenti antiistaminici h2
AU3406489A (en) Use of and agent for reducing side effects of tnf
IT8548976A0 (it) Composizione di un principio farmaceuticamente attivo e fruttosio per alleviare i sintomi di affezioni da raffreddamento in pazienti diabetici
IT8629527V0 (it) Cuffia predisposta per fungere da supporto alle cannule per l'irriga zione auricolare nella prova calori ca dell'esame vestibolare
SE8404425D0 (sv) Medicinska kyldynor, skonhetsdynor, insomningsdynor, solskyddsdynor
KR890012085U (ko) 모니터 본체와 회전 및 경사조절 테이블과의 결합장치